Olintatug Biosimilar Monoclonal Antibody (KAAG1) for Research

Cat No.: GMP-Bios-INN-1310

Anti-KAAG1/RU2AS therapeutic antibody (Pre-made Olintatug biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture,  assay development,  animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Olintatug (development code ADCT-901) is a humanized monoclonal antibody targeting KAAG1. It is developed by ADC Therapeutics for solid tumors. Further development details are under investigation.

Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package Price(In USD)
GMP-Bios-INN-1310-1mg 1mg 3090
GMP-Bios-INN-1310-10mg 10mg
GMP-Bios-INN-1310-100mg 100mg
GMP-Bios-INN-1310-xmg ≥100mg



Product Details

Products Name (INN Index) Pre-Made Olintatug biosimilar, Whole mAb, Anti-KAAG1/RU2AS Antibody: Anti-KAAG1/Kidney-associated antigen 1/RU2 antisense gene protein/RU2AS therapeutic antibody
INN Name Olintatug
Target KAAG1/RU2AS
Format Whole mAb
Derivation Humanized
Species Reactivity Human
CH1+2+3 Isotype G1
VD LC Kappa
Highest_Clin_Trial (Jan '20) TBC
Est. Status Active
100% SI Structure None
99% SI Structure None
95-98% SI Structure None
Year Proposed 2024
Year Recommended 2024
Companies TBC
Conditions Approved TBC
Conditions Active TBC
Conditions Discontinued TBC
Production na
Development Tech na